Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2023 | 02-2023 | 11-2022 | 09-2022 | 08-2022 | |
| Sales | 30,676 | 12,685 | 6,783 | 0 | 10,791 |
| Gross Profit | 30,676 | 12,685 | 6,783 | N/A | 10,791 |
| Operating Expenses | 57,441 | 55,637 | 55,473 | 0 | 57,509 |
| Operating Income | -26,765 | -42,952 | -48,690 | N/A | -46,718 |
| Other Income | 2,488 | 2,219 | 1,973 | 0 | 1,009 |
| Pre-tax Income | -24,277 | -40,733 | -46,717 | 0 | -45,709 |
| Net Income Continuous | -24,277 | -40,733 | -46,717 | N/A | -45,709 |
| Net Income | $-24,277 | $-40,733 | $-46,717 | $N/A | $-45,709 |
| EPS Basic Total Ops | -0.45 | -0.75 | -0.85 | N/A | -0.90 |
| EPS Basic Continuous Ops | -0.45 | -0.75 | -0.85 | N/A | -0.90 |
| EPS Diluted Total Ops | -0.45 | -0.75 | -0.85 | N/A | -0.90 |
| EPS Diluted Continuous Ops | -0.45 | -0.75 | -0.85 | N/A | -0.90 |
| EBITDA(a) | $-24,422 | $-40,590 | $-46,303 | $N/A | $-43,749 |